ScholarIQanswers from OpenAlex & ORCID
Vered Stearns
ResearcherPublications, citations & collaboration network
Vered Stearns is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Vered Stearns have?
ScholarIQindexed works
Vered Stearns has 740 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Vered Stearns have?
ScholarIQcitation count
Vered Stearns has 24,859 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Vered Stearns?
ScholarIQh-index
Vered Stearns has an h-index of 75 in OpenAlex.
What is the i10-index of Vered Stearns?
ScholarIQi10-index
Vered Stearns has an i10-index of 238 in OpenAlex.
What is the ORCID of Vered Stearns?
ScholarIQorcid
The ORCID for Vered Stearns is on the source record.
What is the OpenAlex record for Vered Stearns?
ScholarIQopenalex
The OpenAlex for Vered Stearns is on the source record.
What are the most-cited papers on Vered Stearns?
ScholarIQmost cited works
Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update
Manfred Kaufmann, Gabriel N. Hortobágyi, Aron Goldhirsch, Suzy Scholl, Andreas Makris, Pinuccia Valagussa, Jens‐Uwe Blohmer, W. Eiermann, Raimund Jackesz, W. Jonat, Annette Lebeau, Sibylle Loibl, William R. Miller, Sigfried Seeber, Semiglazov Vf, Roy E. Smith, Rainer Souchon, Vered Stearns, Michael Untch, Gϋnter von Minckwitz
Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer
Julia A. Beaver, Danijela Jelovac, Balukrishna Sasidharan, Rory L. Cochran, Sarah Croessmann, Daniel J. Zabransky, Hong Yuen Wong, Patricia Valda Toro, Justin Cidado, Brian Blair, David Chu, Timothy F. Burns, Michaela J. Higgins, Vered Stearns, Lisa K. Jacobs, Mehran Habibi, Julie R. Lange, Paula J. Hurley, Josh Lauring, Dustin A. VanDenBerg, Jill Kessler, Stacie C. Jeter, Michael L. Samuels, Dianna Maar, Leslie Cope, Ashley Cimino‐Mathews, Pedram Argani, Antonio C. Wolff, Ben Ho Park
Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast Cancer
N. Lynn Henry, Faouzi Azzouz, Zereunesay Desta, Lang Li, Anne Nguyen, Suzanne Lemler, Jill A. Hayden, Karineh Tarpinian, Elizabeth Yakim, David A. Flockhart, Vered Stearns, Daniel F. Hayes, Anna Maria Storniolo
Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors
N. Lynn Henry, Jon T. Giles, Dennis C. Ang, Monika Mohan, Dina Dadabhoy, Jason Robarge, Jill A. Hayden, Suzanne Lemler, Karineh Shahverdi, Penny Powers, Lang Li, David A. Flockhart, Vered Stearns, Daniel F. Hayes, Anna Maria Storniolo, Daniel J. Clauw
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update—Integration of Results From TAILORx
Fabrice André, Nofisat Ismaila, N. Lynn Henry, Mark R. Somerfield, Robert C. Bast, William E. Barlow, Deborah Collyar, M. Elizabeth Hammond, Nicole M. Kuderer, Minetta C. Liu, Catherine Van Poznak, Antonio C. Wolff, Vered Stearns